Physician profile
Viney Soni
NPI 1447341409
$14,422.48
in general payments reported to CMS, 2019-2025
79 companies · $1,903 in 2025
The $1,903 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,679 · 2020: $1,382 · 2021: $2,814 · 2022: $2,399 · 2023: $1,870 · 2024: $2,376 · 2025: $1,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,131 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,131.43 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,411.54 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Abbott Laboratories | $1,173.17 | 2019-2024 | Eterna |
| Glaxosmithkline, LLC. | $1,119.32 | 2019-2025 | Trelegy Ellipta, Nucala |
| Amgen INC. | $802.01 | 2019-2025 | Evenity, Tezspire, Prolia |
| Insmed, INC. | $760.11 | 2019-2025 | Arikayce, Brinsupri |
| Abbvie INC. | $693.69 | 2021-2025 | Ubrelvy, Qulipta |
| Janssen Pharmaceuticals, INC | $541.96 | 2019-2023 | Xarelto |
| Gilead Sciences, INC. | $493.62 | 2021-2024 | Biktarvy |
| Collegium Pharmaceutical, INC. | $478.16 | 2021-2025 | Belbuca |
| Grifols USA, LLC | $456.99 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $437.60 | 2019-2024 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $377.03 | 2019-2025 | Ofev, Jascayd |
| Pfizer INC. | $354.59 | 2019-2025 | |
| Mylan Specialty L.P. | $233.55 | 2019-2024 | Yupelri, Yupelri |
| Medtronic, INC. | $224.10 | 2021-2024 | Signia |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $222.56 | 2019-2025 | |
| Electromed, INC. | $217.34 | 2019-2025 | Smartvest |
| Inari Medical, INC. | $209.51 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Actelion Pharmaceuticals US, INC. | $206.21 | 2024-2025 | Opsumit, Uptravi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $196.49 | 2019-2025 | Relistor, Xifaxan |
| E.R. Squibb & Sons, L.L.C. | $189.36 | 2019-2022 | |
| Boston Scientific Corporation | $172.14 | 2019-2021 | |
| Philips North America LLC | $169.33 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $161.07 | 2019-2022 | |
| Advanced Respiratory, INC | $152.30 | 2019-2021 | |
| Lilly USA, LLC | $151.00 | 2019-2024 | Mounjaro, Zepbound, Emgality |
| Baxter Healthcare | $148.41 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Genzyme Corporation | $135.97 | 2019-2025 | |
| Eisai INC. | $135.74 | 2020-2021 | |
| Averitas Pharma INC. | $119.95 | 2025 | Qutenza |
| Allergan, INC. | $119.69 | 2020 | |
| Scilex Pharmaceuticals INC. | $114.64 | 2020-2024 | Ztlido |
| Biohaven Pharmaceutical Holding Company LTD. | $102.87 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $92.03 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $87.21 | 2019 | |
| Biotronik Nro, INC. | $84.39 | 2024-2025 | Prospera |
| Uswm, LLC | $82.06 | 2021-2024 | Lucemyra, Zimhi |
| Radius Health, INC. | $76.99 | 2024-2025 | Tymlos |
| Nevro Corp. | $73.30 | 2019-2022 | |
| Depuy Synthes Sales INC. | $70.43 | 2019-2025 | Orthovisc |
| Biodelivery Sciences International, INC. | $69.27 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $68.49 | 2025 | |
| Exact Sciences Corporation | $62.74 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Saluda Medical Americas, INC. | $62.20 | 2024-2025 | Evoke |
| Genentech USA, INC. | $59.23 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $57.91 | 2019 | |
| Axsome Therapeutics, INC. | $54.93 | 2025 | Auvelity, Symbravo |
| Fresenius Kabi USA, LLC | $54.00 | 2023-2024 | |
| Pulmonx Corporation | $52.79 | 2019-2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Viatris Specialty LLC | $46.13 | 2025 | Yupelri |
| Valinor Pharma, LLC | $44.90 | 2023 | Movantik |
| Sun Pharmaceutical Industries INC. | $44.38 | 2020-2021 | |
| Amarin Pharma, INC. | $40.33 | 2019 | |
| Novo Nordisk INC | $37.56 | 2021-2023 | Ozempic, Rybelsus |
| Redhill Biopharma INC. | $36.89 | 2020-2022 | |
| Upsher-Smith Laboratories LLC | $36.81 | 2020 | |
| Hikma Pharmaceuticals USA | $35.69 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.36 | 2022 | |
| Almatica Pharma LLC | $35.33 | 2021 | |
| Lundbeck LLC | $35.26 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $33.44 | 2021 | |
| Shire North American Group INC | $32.60 | 2019 | |
| Idorsia Pharmaceuticals US INC | $32.39 | 2023 | Quviviq |
| Arbor Pharmaceuticals, INC. | $31.73 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $28.94 | 2023 | Keytruda |
| Globus Medical, INC. | $25.10 | 2025 | Senza |
| Orexo US, INC. | $23.82 | 2021 | |
| Ani Pharmaceuticals, INC. | $22.94 | 2025 | Purified Cortrophin Gel |
| Incyte Corporation | $20.05 | 2025 | Jakafi |
| Acadia Pharmaceuticals INC | $19.80 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.58 | 2021 | |
| Biogen, INC. | $18.28 | 2019 | |
| Kaleo, INC. | $15.91 | 2019 | |
| Zyla Life Sciences, INC. | $14.73 | 2019 | |
| Inogen, INC. | $14.49 | 2023 | Inogen |
| Xeris Pharmaceuticals, INC. | $13.81 | 2025 | Keveyis |
| Vertiflex, INC. | $12.77 | 2019 | |
| Daiichi Sankyo INC. | $12.42 | 2019 | |
| Avanos Medical | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viney Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.